Safety study of STSP-0902 in healthy men
Part of Kidney & urinary clinical trials.
This study tests a new drug called STSP-0902 to see if it is safe in healthy men. It may help men with low sperm count or poor sperm movement, but the main goal is to check for side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a male between 18 and 50 years old.
- You weigh at least 110 pounds and have a BMI between 19 and 28.
- For the multiple-dose part, you have a low sperm count or low sperm movement (confirmed by two tests).
- You and your partner must use non-drug birth control during the study and for 4 months after, and you cannot donate sperm or plan pregnancy.
- You must avoid hot environments like saunas, hot baths, and electric blankets during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new method for preparing sperm to help with fertility treatments. It is for men who can provide a semen sample and have no active infections or history of certain viruses.
This study tests an investigational drug called STSP-0902, given as multiple doses, to see if it can improve sperm count and movement in men with low sperm count or reduced sperm motility. It aims to help men who have no known cause for their infertility.
This trial tests if a supplement made from Tribulus Terrestris (a plant) can help men with low sperm count (oligospermia) improve their fertility. It may be an option for men who are considering hormone treatments.
This study tests whether a herbal supplement can improve sperm health (count, movement, and shape) in men with fertility problems. You'll need to have low sperm counts and be in general good health, and you'll be asked to follow a routine that includes avoiding ejaculation before tests.
This study tests an experimental medicine called MediReg® for men with severe infertility who have not been able to conceive. It aims to see if the drug is safe and can improve sperm quality, possibly offering a new option for men who have not had success with other treatments.
This trial studies whether gonadotropin therapy (hormones that stimulate sperm production) can help men with low testosterone and very low sperm count. It may be useful if you have been diagnosed with non-obstructive azoospermia and have not had recent surgery or hormone treatment.
Hear when a new Oligozoospermia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.